Technology Commercialization Group (TCG)
Consulting firm (founded 1998) providing strategic advisory and interim management services to life science companies (medical devices, diagnostics, digital health, biotech, and pharmaceuticals). Services include market-entry and commercialization strategy, regulatory and reimbursement planning, partner and investor identification, subsidiary setup and interim executive leadership across US, European and Asian markets.
Industries
Nr. of Employees
small (1-50)
Technology Commercialization Group (TCG)
8801 Fast Park Dr. Suite 301, Raleigh, NC 27617, USA; Heidelberg, Germany (office)
Products
Market-entry assessment framework
Structured assessment framework for evaluating readiness and key factors for expansion into the US market to prioritize actions and support decision-making.
White papers and commercialization guides
Collection of white papers covering reimbursement, regulatory pathways, partnering and interim management to guide commercialization planning.
Market-entry assessment framework
Structured assessment framework for evaluating readiness and key factors for expansion into the US market to prioritize actions and support decision-making.
White papers and commercialization guides
Collection of white papers covering reimbursement, regulatory pathways, partnering and interim management to guide commercialization planning.
Services
Market research, opportunity assessment, product positioning, launch planning and competitive analysis for geographic market entry.
Identification of distribution, licensing and co-development partners; negotiation of agreements and facilitation of strategic collaborations.
Sell-side and buy-side advisory including target identification, valuation support and transaction negotiation.
Advising on financing options, connecting to investor networks and support during term-sheet negotiation.
Provision of interim C-level and senior leadership (including acting CEO roles), executive coaching, team building and short-term operational leadership for spin-outs and companies in transition.
Establish and manage local subsidiaries including sales, marketing, finance, logistics and compliant distribution/quality systems.
Market research, opportunity assessment, product positioning, launch planning and competitive analysis for geographic market entry.
Identification of distribution, licensing and co-development partners; negotiation of agreements and facilitation of strategic collaborations.
Sell-side and buy-side advisory including target identification, valuation support and transaction negotiation.
Advising on financing options, connecting to investor networks and support during term-sheet negotiation.
Provision of interim C-level and senior leadership (including acting CEO roles), executive coaching, team building and short-term operational leadership for spin-outs and companies in transition.
Establish and manage local subsidiaries including sales, marketing, finance, logistics and compliant distribution/quality systems.
Expertise Areas
- Market entry and commercialization
- US, European and Asian market expansion
- Regulatory and reimbursement strategy
- Strategic partnerships, licensing and out-licensing
Key Technologies
- Medical devices
- Point-of-care diagnostics
- Diagnostic imaging
- Digital health platforms
News & Updates
Partners participated in the Wilson Sonsini Medical Device Conference (June 24-25, 2021).
Announcement and presentation of a market-entry assessment tool for US expansion (MedTechLaunch).
Article describing services to help medical device companies enter the Japanese market.
Announcement of company participation at the DIA Annual Meeting in Washington D.C.
Case example describing an acting interim CEO engagement to set strategy and build a leadership team for a spin company.
Case example describing leading out-licensing efforts and identification of strategic partnership for an early-stage gene therapy company.
Partners participated in the Wilson Sonsini Medical Device Conference (June 24-25, 2021).
Announcement and presentation of a market-entry assessment tool for US expansion (MedTechLaunch).
Article describing services to help medical device companies enter the Japanese market.
Announcement of company participation at the DIA Annual Meeting in Washington D.C.
Case example describing an acting interim CEO engagement to set strategy and build a leadership team for a spin company.
Case example describing leading out-licensing efforts and identification of strategic partnership for an early-stage gene therapy company.